(Circulation. 2002;105:251.)
© 2002 American Heart Association, Inc.
Basic Science Reports |
From the Departments of Medicine (K.S., D.L., S.N.) and Pathology (T.K.L.), Montreal Heart Institute and University of Montreal, Canada.
Reprint requests to Stanley Nattel, MD, 5000 Belanger St E, Montreal, Quebec H1T 1C8, Canada. E-mail nattel{at}icm.umontreal.ca
Background All animal studies of atrial tachycardia (AT) remodeling to date have been performed in normal hearts, but clinical atrial fibrillation (AF) often occurs in the setting of heart disease. This study evaluated the effects of a pathological AF substrate on AT-induced remodeling.
Methods and Results Fourteen control dogs, 12 AT-only dogs (400 bpm for 1 week), 14 congestive heart failure (CHF) dogs (CHF only, ventricular tachypacing, 220 to 240 bpm for 5 weeks), and 13 CHF+AT dogs (ventricular tachypacing-induced CHF, 1 week of AT superimposed on the last week of ventricular tachypacing) were studied for evaluation of AT effects in normal hearts (AT-only versus control dogs) and CHF hearts (CHF+AT versus CHF-only dogs). In normal hearts, AT strongly decreased the effective refractory period (ERP) and abolished ERP rate adaptation, whereas conduction velocity was unaltered. In CHF dogs, AT reduced ERP to a significantly lesser extent, did not alter ERP rate adaptation, and reduced conduction velocity. AT alone increased atrial vulnerability to extrastimuli and prolonged AF. In the presence of CHF, AT had no clear effect on atrial vulnerability but increased the prevalence of prolonged AF.
Conclusions The electrophysiological effects of AT are different in hearts with a CHF-induced pathological substrate for AF than in normal hearts. These findings have potentially important implications for understanding how AF occurring in diseased hearts begets AF.
Key Words: heart failure remodeling arrhythmia
This article has been cited by other articles:
![]() |
A. Arenal, T. Datino, L. Atea, F. Atienza, E. Gonzalez-Torrecilla, J. Almendral, L. Castilla, P. L. Sanchez, and F. Fernandez-Aviles Dominant frequency differences in atrial fibrillation patients with and without left ventricular systolic dysfunction Europace, April 1, 2009; 11(4): 450 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bollmann, A. Tveit, D. Husser, M. Stridh, L. Sornmo, P. Smith, and S. B. Olsson Fibrillatory rate response to candesartan in persistent atrial fibrillation Europace, October 1, 2008; 10(10): 1138 - 1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Laurent, G. Moe, X. Hu, B. Holub, H. Leong-Poi, J. Trogadis, K. Connelly, D. Courtman, B. H. Strauss, and P. Dorian Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model Cardiovasc Res, January 1, 2008; 77(1): 89 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Padeletti, P. Pieragnoli, V. Jentzen, and A. Schuchert The comorbidity of atrial fibrillation and heart failure: a challenge for electrical therapies Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I81 - I86. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cingoz, G. Yanulis, E. Ching, K. Fukamachi, and D. W. Wallick Use of Conventional Dual Chamber Pacemakers With Custom Lead Adapters to Induce Atrial Fibrillation or Heart Failure in Dogs Ann. Thorac. Surg., May 1, 2007; 83(5): 1858 - 1862. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Coutu, D. Chartier, and S. Nattel Comparison of Ca2+-handling properties of canine pulmonary vein and left atrial cardiomyocytes Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2290 - H2300. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-R. Neuberger, U. Schotten, Y. Blaauw, D. Vollmann, S. Eijsbouts, A. van Hunnik, and M. Allessie Chronic Atrial Dilation, Electrical Remodeling, and Atrial Fibrillation in the Goat J. Am. Coll. Cardiol., February 7, 2006; 47(3): 644 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-J. Cha, J. R. Ehrlich, L. Zhang, D. Chartier, T. K. Leung, and S. Nattel Atrial Tachycardia Remodeling of Pulmonary Vein Cardiomyocytes: Comparison With Left Atrium and Potential Relation to Arrhythmogenesis Circulation, February 15, 2005; 111(6): 728 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-J. Cha, J. R. Ehrlich, L. Zhang, and S. Nattel Atrial Ionic Remodeling Induced by Atrial Tachycardia in the Presence of Congestive Heart Failure Circulation, September 21, 2004; 110(12): 1520 - 1526. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Baba, T. Yoshikawa, Y. Fukuda, T. Sugiyama, M. Shimada, M. Akaishi, K. Tsuchimoto, S. Ogawa, and M. Fu Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy Eur. Heart J., July 1, 2004; 25(13): 1108 - 1115. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Todd, S. P. Fynn, A. P. Walden, W. J. Hobbs, S. Arya, and C. J. Garratt Repetitive 4-Week Periods of Atrial Electrical Remodeling Promote Stability of Atrial Fibrillation: Time Course of a Second Factor Involved in the Self-Perpetuation of Atrial Fibrillation Circulation, March 23, 2004; 109(11): 1434 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Collins, E. K. Rhee, J. M. Delucca, M. E. Alexander, L. M. Bevilacqua, C. I. Berul, E. P. Walsh, J. E. Mayer, R. A. Jonas, P. J. del Nido, et al. Modification to the Fontan procedure for the prophylaxis of intra-atrial reentrant tachycardia: short-term results of a prospective randomized blinded trial J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 721 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sinno, K. Derakhchan, D. Libersan, Y. Merhi, T. K. Leung, and S. Nattel Atrial Ischemia Promotes Atrial Fibrillation in Dogs Circulation, April 15, 2003; 107(14): 1930 - 1936. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shinagawa, Y.-F. Shi, J.-C. Tardif, T.-K. Leung, and S. Nattel Dynamic Nature of Atrial Fibrillation Substrate During Development and Reversal of Heart Failure in Dogs Circulation, June 4, 2002; 105(22): 2672 - 2678. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |